A senior Food and Drug Administration official said over-the-counter products should be added to the agency's limits on use of prescription pediatric cough syrups containing codeine and hydrocodone.
Currently the FDA limits its warning against use in children only to prescription products.
John Alexander, the FDA's deputy director for the division of pediatric and maternal health in the Office of Drug Evaluation in the Center for Drug Evaluation and Research made his comments during a meeting this week of an FDA advisory panel the was examining the next steps the agency should take in deal with the risks codeine-containing pediatric prescription drugs pose to children. At the meeting
, held Monday, Sept. 11, the panel overwhelmingly urged the FDA to extend its warning against use of the products from anyone 12 and younger to anyone 18 and younger.